Amanote Research

Amanote Research

    RegisterSign In

A Randomized Trial of Varenicline (Chantix) for the Treatment of Spinocerebellar Ataxia Type 3

Neurology - United States
doi 10.1212/wnl.0b013e318257ea5d
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

May 7, 2012

Authors
A. FillaF. SaccaG. De Michele
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

A Randomized Trial of Varenicline (Chantix) for the Treatment of Spinocerebellar Ataxia Type 3

Neurology
Neurology
2012English

Spinocerebellar Ataxia Type 3

2020English

Axonal Inclusions in Spinocerebellar Ataxia Type 3

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2010English

Therapeutic Prospects for Spinocerebellar Ataxia Type 2 and 3

Drugs of the Future
Pharmacology
2009English

Spinocerebellar Ataxia Type 13

2020English

Spinocerebellar Ataxia Type 8

2020English

Spinocerebellar Ataxia Type 12

2020English

Spinocerebellar Ataxia Type 37

2020English

Spinocerebellar Ataxia Type 2

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy